Genital Warts - Human papillomavirus (HPV) references

Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002; 51 (No. RR-6): 53-59.

Clinical Effectiveness Group, Association of Genitourinary Diseases and the Medical Society for the study of Venereal Diseases. National guidelines for the management of anogenital warts. Sex Transm Infect 1999; 75: S71-4.

Bjørge T, Diller J, Anttila T et al. Prospective seroepidemiological study of the role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315: 646-9

Simms I, Fairley C. Epidemiology of genital warts in England and Wales: 1971 to 1994. Genitourin Med 1997; 73: 365-367.

Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence and phlyogenetic algorithms. J Infect Dis 1996; 173 (2): 516

International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans: Human Papillomaviruses. Lyon: International Agency for research on Cancer, 1996.

Bosch F, Manos M, Nunoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Nat Cancer Inst 1995; 87: 796-802

Koutsky LA, Galloway DA, Homes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10: 122-163.